期刊文献+

塞来昔布对大鼠慢性非细菌性前列腺炎的血清IL-8影响及病理学观察 被引量:2

Observation of Celecoxib on Serum IL-8 and Pathology in Rat with Chronic Non-bacterial Prostatitis
下载PDF
导出
摘要 目的观察塞来昔布对慢性非细菌性前列腺炎大鼠模型的血清IL-8影响及病理学变化。方法选择40例SD大鼠,分为4组,1组作为对照组,其余3组建立慢性非细菌性前列腺炎模型,按组别分别给予生理盐水(0.5mL/100g)和不同剂量的塞来昔布(2mg/100g,4mg/100g),连续治疗4周。比较大鼠体重增长、前列腺湿重与脏/体比值以及血清IL-8水平的变化。结果与炎症模型组比较,塞来昔布组大鼠体重明显增加,前列腺湿重与脏/体比值以及血清IL-8水平明显下降,差异有统计学意义(P<0.05),不同剂量塞来昔布组间无明显差异。结论塞来昔布能够降低慢性非细菌性前列腺炎大鼠的血清IL-8水平,减轻前列腺炎症反应,为临床合理用药提供依据。 Objective To observe the change of serum IL-8 and pathological changes in chronic non-bacterial prostatitis rat model by celecoxib Methods There were 40 cases of SD rats were divided into four groups,one as the control group,the other three groups to establish chronic non-bacterial prostatitis rat model. These three groups were given normal saline (0.5mL/lOOg) and different doses of celecoxib (2mg/lO0g,4mg/10Og),continuous treatment for 4 weeks. Comparison of body weight,wet weight of prostate and prostate weight/mouse weight and serum IL-8 levels were observed. Results To inflammation model group,the celecoxib group were significantly increased body weight, wet weight of prostate and prostate weight/mouse weight and serum IL-8 levels were significantly decreased.The difference was significant (P〈0.O5).Different doses of eeleeoxib was no significant difference between groups. Conclusion Celecoxib can make chronic bacterial prostatitis in rats decreased serum levels of IL-8,prostatitis inflammatory reaction reduced,to provide the basis for clinical treatment.
出处 《中国现代医生》 2011年第2期6-7,11,共3页 China Modern Doctor
基金 浙江省温州市医药卫生科研项目 编号:2009B085
关键词 塞来昔布 前列腺炎 白介素-8 病理学 大鼠 Celecoxib Prostatitis Interleukin-8 Pathology Rat
  • 相关文献

参考文献14

  • 1Krieger JN,Riley DE,Cheah PY,et al. Epidemiology of prostatitis: new evidence for a world-wide problem[J]. World J Urol,2003,2:70-74.
  • 2Rizzo M,Marchetti F,Travaglini F,et al. Prevalence, diagnosis and treatment of prostatitis in haly:a prospectire urology outpatient practice study[J]. Br J Urol Int, 2003,92:955-959.
  • 3Schaeffer AJ,Knauss JS,Landis JR,et al. Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Studv[J]. J Urol,2002,168(3):1048-1053.
  • 4曾晓勇,叶章群,杨为民,刘继红,张旭,周惜才,周四维.塞来昔布治疗ⅢA型前列腺炎的临床评估[J].中华男科学杂志,2004,10(4):278-281. 被引量:25
  • 5惠继红,单玉喜,阳东荣,申咏梅.塞来昔布对Ⅲ_B型前列腺炎患者前列腺液中细胞因子的影响及临床评估[J].中国男科学杂志,2007,21(10):21-23. 被引量:7
  • 6魏武然,张唯力,戴君勇.大鼠慢性非细菌性前列腺炎模型的建立[J].中国男科学杂志,2006,20(1):22-24. 被引量:67
  • 7Rowe E,Smith C,Laverick L,et al. A prospective,randomized,placebo controlled,double--blind study of pelvic electromagnetic therapy for the treatment of chronic pelvic pain syndrome with 1 year of followup[J]. J Urol,2005,173(6) :2044-2047.
  • 8胡小朋,白文俊,朱积川,王晓峰.慢性前列腺炎细菌及免疫学研究[J].中华泌尿外科杂志,2002,23(1):29-31. 被引量:147
  • 9Razumov SV,Medvedev AA,Chirun NV,et al. Role of cytokines in the diagnosis of chronic prostafitis[J]. Urologia, 2003,6: 25-28.
  • 10Orhan I,Onur R,Ilhan N,et al. Seminal plasma cytokine levels in the diagnosis of chronic pelvic pain syndrome [J]. Int J Urol, 2001,8 : 495-499.

二级参考文献71

  • 1贺大林,周锋,何辉,史杰,王新阳,赵军,南勋义.前列腺按摩液中IL-8和TNF-α测定在慢性前列腺炎诊断、分型中的临床意义[J].中华男科学杂志,2004,10(10):740-742. 被引量:39
  • 2段志国,杨为民.慢性前列腺炎患者前列腺液中IL-2、IL-8及IL-10水平分析[J].中华男科学杂志,2005,11(3):201-203. 被引量:46
  • 3刘肖平.特异性COX-2抑制药临床应用安全性新动态[J].实用疼痛学杂志,2005,1(2):66-69. 被引量:4
  • 4James M J, Penglis PS, Caughey GE, et al. Eicosanoid production by human monocytes: does COX-2 contribute to a self-limiting inflammatory response [ J ]? Inflamm Res, 2001,50 (5) :249-253
  • 5Schaeffer AJ, Datta NS, Fowler JE Jr, et al. Overview summary statement. Diagnosis and management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) [J]. Urology, 2002, 60(6Suppl) :1-4.
  • 6Gurunadha Rao Tunuguntla HS, Evans CP. Management of prostatitis[ J ]. Prostate Cancer Prostatic Dis, 2002, 5 (3) : 172-179.
  • 7Simon LS. COX-2 inhibitom. Are they nonsteroidal anti-inflammatory drugs with a better safety profile [ J ] ? Gastmenterol Clin North Am, 2001, 30(4) :1011-1025.
  • 8Goldenberg MM. Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis[J].Clin Ther, 1999, 21(9) :1497-1513.
  • 9Nickel JC, Pontari M, Moon T, et al. A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis[J]. J Urol, 2003, 169(4) :1401-1405.
  • 10Tanaka A, Hase S, Miyazawa T, et al. Up-regulation of cyclooxygenase-2 by inhibition of cyclooxygenase-1: a key to nonsteroidal anti-inflammatory drug-induced intestinal damage[J]. J Pharmacol Exp Ther, 2002, 300(3):754-761.

共引文献319

同被引文献27

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部